Torrent Pharma shares jump 8% on strong Q4 earnings. How to trade stock now?
Torrent Pharmaceuticals' shares surged 8% after the company reported a profit of INR 287 crore ($38.4m) during Q4 FY22, compared to a net loss of INR 118 crore in the same period a year ago. The drug maker's revenue rose to INR 2,491 crore during the fourth quarter, up from INR 2,131 crore in the year-ago period. While Motilal Oswal has taken a "neutral" view on the counter, Nuvama and Prabhudas Lilladher have a "buy" rating on the stock, while Kotak Institutional Equities recommend a "reduce".